CT SB00005

Imposes a 6.35% surcharge on gross receipts of opioid-controlled substances (Schedule II-V) sold by manufacturers or wholesalers to pharmacies, physicians, hospitals, and other licensed entities, effective January 1, 2017.

Allows refunds of the surcharge when opioids are dispensed to beneficiaries of Medicare Part D, other federal/state health programs exempt from taxation, state health programs, or municipal employee/workers' compensation plans.

Requires manufacturers and wholesalers to register with the Commissioner of Revenue Services and file quarterly surcharge returns; establishes penalties of $1,000 for failure to register and 10% of unpaid amounts or $50 (whichever is greater) for late payments.

Establishes a nonlapsing opioid abuse prevention and treatment account within the General Fund to receive surcharge revenues for grants-in-aid to regional opioid prevention and treatment programs.

Designates the Department of Mental Health and Addiction Services to distribute grants-in-aid to regional opioid abuse prevention and treatment programs following state and federal protocols, with a report required by January 31, 2018.